Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QB02BD08
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
NDF-RT |
N0000184169
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
WHO-ATC |
B02BD08
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
185904
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NOVOSEVEN (AUTHORIZED: HEMOPHILIA B)
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
192404
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
186004
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
NDF-RT |
N0000184169
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NOVOSEVEN (AUTHORIZED: FACTOR VII DEFICIENCY)
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
NOVOSEVEN (AUTHORIZED: THROMBASTHENIA)
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
186104
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/07/436
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
190104
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
190004
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
189904
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
26588
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
213005
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
||
|
FDA ORPHAN DRUG |
186204
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
AC71R787OV
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
100000085428
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
1228539-24-9
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
ALTERNATIVE | |||
|
10042
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
ALTERNATIVE | |||
|
N0000007914
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | Blood Coagulation Factors [Chemical/Ingredient] | ||
|
N0000184153
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | Increased Coagulation Factor IX Activity [PE] | ||
|
DB00036
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
SUB06591MIG
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
N0000184154
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | Increased Coagulation Factor X Activity [PE] | ||
|
5159
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
314620
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
ALTERNATIVE | |||
|
CHEMBL2108334
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
AC71R787OV
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
1311500
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
253149
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
C81125
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
Recombinant factor VIIa
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
C103587
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
6931
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
102786-61-8
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY | |||
|
CHEMBL2108405
Created by
admin on Sat Dec 16 01:21:21 UTC 2023 , Edited by admin on Sat Dec 16 01:21:21 UTC 2023
|
PRIMARY |
ACTIVE MOIETY